Elevated Pulse Pressure is Associated with Hemolysis, Proteinuria and Chronic Kidney Disease in Sickle Cell Disease
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
A seeming paradox of sickle cell disease is that patients do not suffer from a high prevalence of systemic hypertension in spite of endothelial dysfunction, chronic inflammation and vasculopathy. However, some patients do develop systolic hypertension and increased pulse pressure, an increasingly recognized major cardiovascular risk factor in other populations. Hence, we hypothesized that pulse pressure, unlike other blood pressure parameters, is independently associated with markers of hemolytic anemia and cardiovascular risk in sickle cell disease. We analyzed the correlates of pulse pressure in patients (n = 661) enrolled in a multicenter international sickle cell trial. Markers of hemolysis were analyzed as independent variables and as a previously validated hemolytic index that includes multiple variables. We found that pulse pressure, not systolic, diastolic or mean arterial pressure, independently correlated with high reticulocyte count (beta = 2.37, p = 0.02) and high hemolytic index (beta = 1.53, p = 0.002) in patients with homozygous sickle cell disease in two multiple linear regression models which include the markers of hemolysis as independent variables or the hemolytic index, respectively. Pulse pressure was also independently associated with elevated serum creatinine (beta = 3.21, p = 0.02), and with proteinuria (beta = 2.52, p = 0.04). These results from the largest sickle cell disease cohort to date since the Cooperative Study of Sickle Cell Disease show that pulse pressure is independently associated with hemolysis, proteinuria and chronic kidney disease. We propose that high pulse pressure may be a risk factor for clinical complications of vascular dysfunction in sickle cell disease. Longitudinal and mechanistic studies should be conducted to confirm these hypotheses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Alternatively, decreased autoregulation may allow the detrimental effects of elevated cerebral blood flow, pulse pressure (67), and velocity to be transmitted to the microcirculation and cause damage, as occurs in older individuals with atherosclerosis.”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694 · cited 1×
“[5] Both and other studies have shown that elevations of systolic blood pressure over baseline are detrimental in SCD patients and predict a risk of vascular complications including stroke,[1, 27] kidney disease,[28, 29] and pulmonary hypertension.”
ResultManagement of Sickle Cell Disease: Summary of the 2014 Evidence-Based Report by Expert Panel Members
Yawn, B. P., Buchanan, G. R., Afenyi-Annan, A. N., Ballas, S. K., Hassell, K. L., James, A. H., Jordan, L., Lanzkron, S. M., Lottenberg, R., Savage, W. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.10517 · Cited by 1,599 · cited 1×
“These are recognized valuable screening tools of kidney dysfunction by the recently published sickle cell guidelines.[36] In summary, our results show that pulse pressure is closely linked to hemolysis in SCD and suggest that it may be an important predictor of cardiovascular risk.”
BackgroundCell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330 · cited 1×
“[4–7] Again, paradoxically, endothelial function studies in humans clearly show that many patients, especially those with higher rates of hemolytic anemia, exhibit impaired response to major endothelial vasodilators, such as nitric oxide.[6, 8, 9] More recent studies have also shown that when an appropriate control po…”
BackgroundSelf-citationCell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., et al. (2002) · Nature Medicine · doi:10.1038/nm799 · Cited by 1,097
Abnormal rheology of oxygenated blood in sickle cell anemia
Chien, S., Usami, S., & Bertles, J. F. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106273 · Cited by 356 · cited 1×
“[4–7] Again, paradoxically, endothelial function studies in humans clearly show that many patients, especially those with higher rates of hemolytic anemia, exhibit impaired response to major endothelial vasodilators, such as nitric oxide.”
BackgroundKaul, D. K., Fabry, M. E., & Nagel, R. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.9.3356 · Cited by 335 · cited 1×
“Moreover, hemolysis is also linked to microvascular dysfunction in SCD, since the primary pathogenic process in this disease occurs at the level of the post-capillary venules and is characterized by cellular adhesion, vaso-occlusion, hemolysis and ischemiareperfusion injury.[30] Microvascular damage would lead to loss…”
BackgroundMinneci, P. C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25040 · Cited by 331 · cited 1×
“High plasma levels of free hemoglobin from hemolyzed RBC lead to nitric oxide depletion and reactive oxygen species formation which cause impaired vascular relaxation and increased arterial stiffness.[20] In addition, ischemia/reperfusion injury from acute episodes of vaso-occlusion and hemolysis also lead to the gene…”
BackgroundFalk, R. J., Scheinman, J., Phillips, G., Orringer, E., Johnson, A., & Jennette, J. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204023261402 · Cited by 300 · cited 9×
“This hypothesis is supported by recent epidemiological evidence showing that systolic blood pressure rises as biomarkers of pulmonary hypertension and intravascular hemolysis increase, while diastolic blood pressure decreases as hemoglobin levels drop in SCD, leading to subgroups of patients developing systolic hypert…”
BackgroundInfluentialPegelow, M., Colangelo, M., Steinberg, M., Wright, P., Smith, M., Phillips, M., & Vichinsky, M. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00407-x · Cited by 274 · cited 3×
“[5] Both and other studies have shown that elevations of systolic blood pressure over baseline are detrimental in SCD patients and predict a risk of vascular complications including stroke,[1, 27] kidney disease,[28, 29] and pulmonary hypertension.”
Result
Cited by
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
Self-citationWare, R. E., de Montalembert, M., Tshilolo, L., & Abboud, M. R. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30193-9 · Cited by 977
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Self-citationCardiovascular complications and risk of death in sickle-cell disease
Gladwin, M. T. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00647-4 · Cited by 164
Self-citationKidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC
Drawz, P. E., Ayyappan, S. R., Nouraie, M. S., Saraf, S. L., Gordeuk, V. R., Hostetter, T. H., Gladwin, M. T., & Little, J. A. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03940415 · Cited by 116
Self-citationDeterminants of resting cerebral blood flow in sickle cell disease
Bush, A., Borzage, M., Choi, S., Václavů, L., Tamrazi, B., Nederveen, A. J., Coates, T. D., & Wood, J. C. (2016) · American Journal of Hematology · doi:10.1002/ajh.24441 · Cited by 98
“Systemic pulse pressures widen with worsening anemia [32].”
BackgroundChronic organ failure in adult sickle cell disease
Vichinsky, E. P. (2017) · Hematology · doi:10.1182/asheducation-2017.1.435 · Cited by 74
“Relative hypertension and elevated pulse pressure are high-risk factors for renal disease.(50) Periodic screening for microalbuminuria, hematuria, and estimated glomerular filtration rate are standard.”
BackgroundThe spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle trait
Naik, R. P. P., & Derebail, V. K. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2017.1395279 · Cited by 62
“[50] Nonetheless, arterial hypertension may be a risk factor for CKD in SCD.”
Arterial compliance probe for cuffless evaluation of carotid pulse pressure
Joseph, J., Nabeel, P. M., Shah, M. I., & Sivaprakasam, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202480 · Cited by 52
Measuring success: utility of biomarkers in sickle cell disease clinical trials and care
Kalpatthi, R. V., & Novelli, E. M. (2018) · Hematology · doi:10.1182/asheducation-2018.1.482 · Cited by 51
“However, other markers of hemolysis, such as lactate dehydrogenase (LDH), bilirubin, and reticulocyte count, either alone or in combination (ie, hemolytic index) have been useful to identify a subset of patients at high risk of hemolysis-related complications, including pulmonary hypertension, leg ulcers, priapism, an…”
BackgroundSelf-citationLactate dehydrogenase in sickle cell disease
Stankovic, K., & Lionnet, F. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.04.035 · Cited by 44
Prevalence of relative systemic hypertension in adults with sickle cell disease in Ghana
Kuma, A. B.-A., Owusu-Ansah, A. T., Ampomah, M. A., Sey, F., Olayemi, E., Nouraie, M. S., & Ofori-Acquah, S. F. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190347 · Cited by 29
Möckesch, B., Charlot, K., Jumet, S., Romana, M., Divialle‐Doumdo, L., Hardy‐Dessources, M., Petras, M., Tressières, B., Tarer, V., Hüe, O., et al. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.02.001 · Cited by 24
Non-invasive urinary biomarkers of renal function in sickle cell disease: an overview
Laurentino, M. R., Filho, S. L. A. P., Parente, L. L. C., da Silva, G. B., Daher, E. D. F., & Lemes, R. P. G. (2019) · Annals of Hematology · doi:10.1007/s00277-019-03813-9 · Cited by 20
Safdar, O. Y., Baghdadi, R. M., Alahmadi, S. A., Fakieh, B. E., & Algaydi, A. M. (2022) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v11.i1.14 · Cited by 15
Gladwin, M. T., Gordeuk, V. R., Desai, P. C., Minniti, C. P., Novelli, E. M., Morris, C. R., Ataga, K. I., Castro, L. D., Curtis, S. A., Rassi, F. A. E., et al. (2024) · The Lancet Haematology · doi:10.1016/s2352-3026(24)00045-0 · Cited by 15
Self-citationClinical Manifestations of Sickle Cell Disease Across the Lifespan
Pecker, L. H., & Little, J. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-62328-3_1 · Cited by 18
Nguweneza, A., Oosterwyk, C., Banda, K., Nembaware, V., Mazandu, G. K., Kengne, A. P., & Wonkam, A. (2022) · Expert Review of Hematology · doi:10.1080/17474086.2022.2043743 · Cited by 13
“, found that higher pulse pressure was associated with markers of hemolysis, elevated serum creatinine and with proteinuria in SCD patients [25].”
BackgroundInfluentialShilo, N. R., & Morris, C. R. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2017.1364989 · Cited by 13
“However, there is an association of PH with renal insufficiency in adults, so monitoring for an increasing trend in creatinine levels, albuminuria/proteinuria and glomerular filtration rate may be useful [149,150].”
BackgroundMakubi, A. N., Mmbando, B. P., Novelli, E. M., Lwakatare, J., Soka, D., Marik, H., Tibarazwa, K., Ngaeje, M., Newton, C. R. J. C., Gladwin, M. T., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.14330 · Cited by 10
“‘In the current young study population, the association between pulse pressure and hypertension might be related to increased stroke volume as a compensatory mechanism, similar to that in patients with chronic haemolytic anaemia (Novelli et al, 2014).”
ResultSelf-citationNguweneza, A., Bitoungui, V. J. N., Mnika, K., Mazandu, G. K., Nembaware, V., Kengne, A. P., & Wonkam, A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.924722 · Cited by 7
Caracterización de las complicaciones renales en pacientes con anemia de células falciformes
López, M. C. I., Rosas, L. F. R., Echavarría-Ospina, L., & Serna-Higuita, L. M. (2020) · Revista chilena de pediatría · doi:10.32641/rchped.v91i1.1274 · Cited by 7
Unmasking hypertension in children and adolescents with sickle/beta‐thalassemia
Stabouli, S., Antza, C., Papadopoulou, E., Teli, Α., Kotsis, V., & Economou, M. P. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.13957 · Cited by 7
Pulmonary Hypertension and Left Ventricular Geometric Types in Sickle Cell Anemia
Oni, O. O., Odeyemi, A. O., Olasinde, Y. T., Odeyemi, A. O., Olufemi-Aworinde, K. J., Abolarin, A. T., & Ala, O. A. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.06.100 · Cited by 6
Clinical and Genetic Predictors of Sickle Cell Nephropathy: A Global Systematic Review
Banda, K., Nguweneza, A., Mnika, K., Nembaware, V., Chagaluka, G., & Wonkam, A. (2025) · OMICS A Journal of Integrative Biology · doi:10.1177/15578100251359276 · Cited by 4
Amama, E. A., Udefa, A. L., Beshel, F. N., Archibong, E. A., Okpa, S., Nwangwa, J. N., Felix, N. I., & Akronyi, G. (2021) · Physiology and Pharmacology · doi:10.52547/phypha.26.3.8 · Cited by 4
Olabode, O. P., Akinlade, O. M., Babatunde, A. S., Abdulazeez, M. I., Biliaminu, S. A., Oyabambi, A. O., Olatunji, V. A., Soladoye, A. O., & Olatunji, L. A. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1499118 · Cited by 4
“Elevated pulse pressure (PP), a surrogate of arterial stiffness (Novelli et al. 2014), has of recent emerged to be independently associated with cardiovascular disease (CVD) and is considered to also be a poor prognostic factor in patients with increased risk of CVD (Fernandez-Fresnedo et al. 2006).”
BackgroundRevuelta, K. L., & Andrés, M. P. R. (2019) · Oxford University Press eBooks · doi:10.1093/med/9780190611620.003.0036 · Cited by 4
Richerson, W. T., Aumann, M. A., Song, A. K., Eisma, J. J., Davis, S. M., Milner, L., Garza, M. E., Davis, L. T., Martin, D., Jordan, L. C., et al. (2024) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x241270283 · Cited by 3
“33 Flow velocities are also associated with the phase of the cardiac cycle, becoming elevated during peak systole, and depressed during diastole.”
Leg ulcers are indicators of systemic dysfunction in individuals with sickle cell disease
Jackson, T. A., Buscetta, A. J., Ramirez, H. C., Bonham, V. L., & Minniti, C. P. (2024) · American Journal of Hematology · doi:10.1002/ajh.27250 · Cited by 2
Ramsay, Z., Ali, A., Grant, J., & Asnani, M. (2024) · British Journal of Haematology · doi:10.1111/bjh.19667 · Cited by 2
“20,21 All continuous numerical features were scaled, and categorical data were one-hot encoded.”
Glomerular hyperfiltration in Yemeni children with sickle cell disease
Al-Saqladi, A.-W. M., & Al-Musawa Fatima, E. (2021) · Journal of Clinical Nephrology · doi:10.29328/journal.jcn.1001065 · Cited by 1
Correlates of nocturnal hypoxemia in children with sickle cell disease
Rani, S., Mahon, B., Afolabi‐Brown, O., Bernstein, B. A., Apollonsky, N., & Miller, R. E. (2024) · Journal of sickle cell disease. · doi:10.1093/jscdis/yoae013 · Cited by 1
Mboliasa, P. I., Lepira, F. B., Makulo, J.-R. R., Nkodila, A. N., Sumaili, E. K., Bukabau, J. B., Mokoli, V. M., Longo, A., Zinga, C. V., Kanjingulu, F. M. P., et al. (2018) · World Journal of Cardiovascular Diseases · doi:10.4236/wjcd.2018.83021
The many facets of cardiopulmonary complications in sickle cell disease
d’Humières, T., Jeune, S. L., Luna, G. D., Moulin, T., Boyer, L., Derbel, H., Iles, S., Lellouche, N., Fiore, A., Dérumeaux, G., et al. (2026) · Seminars in Hematology · doi:10.1053/j.seminhematol.2026.05.007 · Cited by 1
Metadata
- Authors
- Novelli, E. M., Hildesheim, M., Rosano, C., Vanderpool, R., Simon, M., Kato, G. J., & Gladwin, M. T.
- Affiliations
- University of Pittsburgh (US)
- National Institutes of Health (US)
- Corresponding author
- Novelli, Enrico M.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-12-05
- Volume
- 9
- Issue
- 12
- Pages
- e114309
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4257593
- OpenAlex
- W1995941333
- Cited by
- 38
- References
- 37
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 5 · 2023: 1 · 2022: 4 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 6 · 2017: 8 · 2016: 4 · 2015: 1
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- D-Scholarship@Pitt (University of Pittsburgh) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, public-domain)
- Funders
- Hemophilia Center of Western Pennsylvania
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Keywords
- sickle cell disease, pulse pressure, hemolysis, reticulocyte count, hemolytic index, proteinuria, chronic kidney disease, hypertension, cardiovascular risk, endothelial dysfunction, serum creatinine
- MeSH terms
- Adolescent, Adult, Anemia, Sickle Cell, Blood Pressure, Child, Female, Hemolysis, Humans, Male, Middle Aged, Proteinuria, Biomarkers, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.